ARTV Artiva Bio drops 867 after Q4 2025 EPS posts narrow miss versus analyst estimates CRAC CrownReserve quarterly earnings details are still pending leadership will lay out core strategic priorities at next weeks investor call UZD Array posts 33 percent Q4 2025 EPS miss as shares edge down 025 percent in regular trading